SAM
AGN

Sandell Asset Management’s Allergan plc AGN Stock Holding History

Sandell Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-235,000
Closed -$41.6M – 67
2020
Q1 		$41.6M Buy
235,000
+15,000
+7% +$2.82M 9.06% 3
2019
Q4 		$42.1M Buy
220,000
+44,032
+25% +$7.94M 6.8% 3
2019
Q3 		$29.6M Buy
175,968
+121,968
+226% +$19.9M 9.95% 4
2019
Q2 		$9.04M Buy
+54,000
New +$7.48M 1.02% 17

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sandell Asset Management's AGN Position: Q2 2020 in Review

Sandell Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 235,000 shares — an estimated $41.6M sold.

Sandell Asset Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $42.1M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sandell Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sandell Asset Management sold 235,000 Allergan plc shares in Q2 2020, an estimated $41.6M.
  • Sandell Asset Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Sandell Asset Management's Allergan plc position peaked at $42.1M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sandell Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.